HUE059963T2 - Melatonintámogató baktériumok szelektálása és felhasználása az infantilis kólika csökkentésére - Google Patents

Melatonintámogató baktériumok szelektálása és felhasználása az infantilis kólika csökkentésére

Info

Publication number
HUE059963T2
HUE059963T2 HUE19742381A HUE19742381A HUE059963T2 HU E059963 T2 HUE059963 T2 HU E059963T2 HU E19742381 A HUE19742381 A HU E19742381A HU E19742381 A HUE19742381 A HU E19742381A HU E059963 T2 HUE059963 T2 HU E059963T2
Authority
HU
Hungary
Prior art keywords
melatonin
selection
reduce
infantile colic
supporting bacteria
Prior art date
Application number
HUE19742381A
Other languages
English (en)
Inventor
Stefan Roos
Bo Moellstam
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1812079.0A external-priority patent/GB201812079D0/en
Priority claimed from GBGB1905470.9A external-priority patent/GB201905470D0/en
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of HUE059963T2 publication Critical patent/HUE059963T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165Heterorings having nitrogen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • C12P19/40Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/03Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03031Nucleotidase (3.1.3.31)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HUE19742381A 2018-07-24 2019-07-24 Melatonintámogató baktériumok szelektálása és felhasználása az infantilis kólika csökkentésére HUE059963T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1812079.0A GB201812079D0 (en) 2018-07-24 2018-07-24 Selection method
GBGB1905470.9A GB201905470D0 (en) 2019-04-17 2019-04-17 Selection method

Publications (1)

Publication Number Publication Date
HUE059963T2 true HUE059963T2 (hu) 2023-01-28

Family

ID=67390083

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE19742381A HUE059963T2 (hu) 2018-07-24 2019-07-24 Melatonintámogató baktériumok szelektálása és felhasználása az infantilis kólika csökkentésére

Country Status (25)

Country Link
US (1) US11911424B2 (hu)
EP (2) EP4086359A1 (hu)
JP (1) JP7488199B2 (hu)
KR (1) KR20210035077A (hu)
CN (2) CN117487686A (hu)
AU (1) AU2019309426A1 (hu)
BR (1) BR112020023868A2 (hu)
CA (1) CA3099255A1 (hu)
CL (1) CL2020003070A1 (hu)
CO (1) CO2020014673A2 (hu)
DK (1) DK3701051T3 (hu)
ES (1) ES2928223T3 (hu)
GE (1) GEP20237507B (hu)
HR (1) HRP20221209T1 (hu)
HU (1) HUE059963T2 (hu)
IL (1) IL305597B1 (hu)
LT (1) LT3701051T (hu)
MX (1) MX2020012770A (hu)
PH (1) PH12020551922A1 (hu)
PL (1) PL3701051T3 (hu)
PT (1) PT3701051T (hu)
RS (1) RS63624B1 (hu)
SG (1) SG11202010900PA (hu)
WO (1) WO2020020982A1 (hu)
ZA (1) ZA202006891B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112739814B (zh) * 2018-07-24 2023-12-08 生命大地女神有限公司 使用能够增加腺苷水平的细菌菌株的治疗方法
CN115040551B (zh) * 2022-06-08 2023-07-25 华南农业大学 一株调控宿主褪黑素水平的罗伊氏乳酸杆菌ln0214的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374924B2 (en) 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
US20080058405A1 (en) * 2006-07-31 2008-03-06 Oregon Health & Science University Replicating melatonin signaling in a fetus, newborn or suckling infant
KR100913406B1 (ko) 2008-03-25 2009-08-21 광주과학기술원 Th1-매개 면역 질환의 예방 또는 치료용 조성물
KR100913405B1 (ko) 2008-03-25 2009-08-21 광주과학기술원 Th2-매개 면역 질환의 예방 또는 치료용 조성물
CA2742476A1 (en) 2008-11-03 2010-06-03 Nestec S.A. A nutritional composition comprising probiotics and improving sleep patterns
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
EP2609813A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system
ITMI20120471A1 (it) 2012-03-26 2013-09-27 Giovanni Mogna Composizione a base di ceppi di batteri bifidobacterium longum in grado di aiutare il prolungamento della vita
GB201206599D0 (en) * 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
EP2674162A1 (en) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
RU2692671C2 (ru) * 2014-01-23 2019-06-26 Биогайа Аб Выбор агентов, модулирующих гастроинтестинальную боль
US20170216375A1 (en) * 2014-05-20 2017-08-03 Biogaia Ab Neonatal Microbiome Supplementation
JP6637419B2 (ja) * 2014-06-30 2020-01-29 株式会社明治 プリン体吸収を抑制する乳酸菌及びその用途
JP6581208B2 (ja) * 2014-12-23 2019-09-25 イリヤ ファーマ エービー 創傷治癒の方法
JP2018510631A (ja) 2015-03-26 2018-04-19 バイオガイア・エイビーBiogaia AB ヒスタミン産生細菌株及びがんにおけるそれらの使用
CN110087656A (zh) 2016-05-27 2019-08-02 拜奥加亚公司 肌苷在治疗T-reg缺乏中的应用
WO2017223364A1 (en) * 2016-06-23 2017-12-28 Erdman Susan E Canine microbe preparations for increasing oxytocin
CN108029923A (zh) * 2017-12-13 2018-05-15 杭州滨研生物科技有限公司 一种具有抗过敏效果的益生菌固体饮料生产配方
CN112739814B (zh) 2018-07-24 2023-12-08 生命大地女神有限公司 使用能够增加腺苷水平的细菌菌株的治疗方法

Also Published As

Publication number Publication date
JP7488199B2 (ja) 2024-05-21
DK3701051T3 (da) 2022-10-03
RS63624B1 (sr) 2022-10-31
GEP20237507B (en) 2023-05-25
KR20210035077A (ko) 2021-03-31
CN112236513B (zh) 2023-09-19
PH12020551922A1 (en) 2021-06-14
IL305597B1 (en) 2024-04-01
CA3099255A1 (en) 2020-01-30
CO2020014673A2 (es) 2020-12-21
HRP20221209T1 (hr) 2022-12-09
EP4086359A1 (en) 2022-11-09
JP2021531739A (ja) 2021-11-25
MX2020012770A (es) 2021-02-15
ES2928223T3 (es) 2022-11-16
SG11202010900PA (en) 2020-12-30
CN112236513A (zh) 2021-01-15
CL2020003070A1 (es) 2021-04-05
PT3701051T (pt) 2022-10-17
AU2019309426A1 (en) 2021-03-11
CN117487686A (zh) 2024-02-02
BR112020023868A2 (pt) 2021-04-06
EP3701051B1 (en) 2022-07-13
LT3701051T (lt) 2022-12-12
US20220347237A1 (en) 2022-11-03
IL305597A (en) 2023-11-01
ZA202006891B (en) 2023-03-29
EP3701051A1 (en) 2020-09-02
PL3701051T3 (pl) 2022-10-31
WO2020020982A1 (en) 2020-01-30
US11911424B2 (en) 2024-02-27

Similar Documents

Publication Publication Date Title
ZA201906485B (en) Treatment of inflammatory diseases with inhibitors of c5a activity
EP2456483A4 (en) BIPHASIC AND DYNAMICALLY ADJUSTABLE SUPPORT DEVICE AND METHODS OF RELEASE AND REPLACEMENT CAPACITIES FOR THE TREATMENT OF DISEASES OF THE DISEASE
IL276788A (en) Compounds with activity that causes iron-dependent cell death and methods of using them
IL292810A (en) Therapeutic compounds and methods of use
IL285730A (en) Compounds with proptosis-inducing activity and methods of using them
ZA202006891B (en) Selection and use of melatonin supporting bacteria to reduce infantile colic
IL271074A (en) Treatment of inflammatory diseases with c5a activity inhibitors
IL272036A (en) Methods and compositions for treating pain using capsaicin
IL287226A (en) Therapeutic microbubbles of probiotic bacteria
IL290915A (en) Bacterial buginosis treatment
GB2615478B (en) Therapeutic and prophylactic use of microorganisms
IL261878A (en) Treatment of disorders and skin diseases related to bacterial layers
PT3624812T (pt) Métodos e tratamento de trauma
GB201907305D0 (en) Treatment of conditions
MA50489A (fr) Sélection et utilisation de bactéries favorisant la production de mélatonine pour réduire la colique infantile
FI4225291T3 (fi) Kolangiopatioiden hoito seladelpaarilla
IL290548A (en) Bacteria and methods of using them
GB201815000D0 (en) Treatment of hypothroidism and related conditions
EP3681456C0 (en) EASY TO CLEAN AND MAINTAIN HOSPITAL BED AND PATIENT SUPPORT
ZA201904327B (en) Treatment of skin conditions
IL281969A (en) New medical use of oxalate-reducing bacteria
IL278876A (en) Use of vibegron to treat pain associated with irritable bowel syndrome
GB202101251D0 (en) Treatment of conditions
GB201917253D0 (en) Treatment of conditions
EP4003283C0 (en) TREATMENT OF INFLAMMATORY SKIN CONDITIONS